Literature DB >> 7091935

The information content from renal biopsy in systemic lupus erythematosus.

Q Whiting-O'Keefe, J E Henke, M A Shearn, J Hopper, C G Biava, W V Epstein.   

Abstract

We analyzed data for the 12-month period after renal biopsy was done in 130 patients with systemic lupus erythematosus to examine whether renal biopsy provides useful information on the nephritis of systemic lupus erythematosus beyond that clinically available. A stepwise linear regression analysis was used to construct a linear before biopsy model that predicted the change in renal function 12 months after biopsy. The model included serum creatinine, patient age, 24-hour urine protein, a laboratory index of renal activity, antibodies to DNA, urinalysis protein, change in inverse creatinine from 6 weeks before biopsy, and urine light chain protein, and had a squared multiple correlation coefficient (R2) of 0.246. Four prospectively chosen renal biopsy variables (glomerular cell counts, percent of sclerotic glomeruli, percent of glomeruli with crescents, and interstitial fibrosis) resulted in a 0.079 improvement in R2 (p less than or equal to 0.012). Both the percent glomerular sclerosis (p less than or equal to 0.0032) and subendothelial deposits shown by electron microscopy (p less than or equal to 0.0026) added significantly to the predictive power of the before biopsy model. Histologic classification did not add significantly to the before biopsy model. The renal biopsy information increased the power of a linear regression model to predict the effect of 12 months of treatment of active lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7091935     DOI: 10.7326/0003-4819-96-6-718

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  Lupus nephritis. Middlesex, October 20, 1988. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

2.  Lupus nephritis: more answers needed.

Authors:  F Wang
Journal:  J R Soc Med       Date:  1985-08       Impact factor: 5.344

3.  New approaches to treating systemic lupus erythematosus.

Authors:  D Wofsy
Journal:  West J Med       Date:  1987-08

Review 4.  Prognosis in systemic lupus erythematosus.

Authors:  J M Esdaile
Journal:  Springer Semin Immunopathol       Date:  1994

Review 5.  Lupus nephritis in children.

Authors:  K L Gupta
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

6.  Systemic lupus erythematosus without clinical renal abnormalities: renal biopsy findings and clinical course.

Authors:  J R O'Dell; R C Hays; S J Guggenheim; J C Steigerwald
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

Review 7.  Newer drugs for the treatment of lupus nephritis.

Authors:  Dudy G Kuiper-Geertsma; Ronald H W M Derksen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Lupus nephritis in childhood and adolescence.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

9.  ARAMIS today: moving toward internationally distributed databank systems for follow-up studies.

Authors:  F Wolfe; J F Fries
Journal:  Clin Rheumatol       Date:  1987-09       Impact factor: 2.980

10.  Clinicopathological study of the WHO classification in childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciaran Duffy; Chantal Bernard; Rosie Scuccimarri; Karen Watanabe Duffy; Rhoda Kagan; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.